References
- Conville PS, Witebsky FG. Nocardia, Rhodococcus, Gordona, Actinomadura, Streptomyces, and other aerobic actinomycetes. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology, 9th edn. Washington, DC: American Society for Microbiology; 2007. p. 515–42.
- Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19: 259–82
- Sorrell TC, Mitchell DH, Iredell JR. Nocardia species. Principles and practice of infectious diseases6th edn, GL Mandell, JE Bennett, R Dolin. Churchill Livingstone, Philadelphia, Pennsylvania 2005; 2916–24
- Beaman BL, Burnside J, Edwards B, Causey W. Nocardial infections in the United States, 1972–1974. J Infect Dis 1976; 134: 286–9
- Boiron P, Provost F, Chevrier G, Dupont B. Review of nocardial infections in France, 1987–1990. Eur J Clin Microbiol Infect Dis 1992; 11: 709–14
- Farina C, Boiron P, Ferrari I, Provost F, Goglio A. Report of human nocardiosis in Italy between 1993 and 1997. Eur J Epidemiol 2001; 17: 1019–22
- Matulionyte R, Rohner P, Uckay I, Lew D, Garbino J. Secular trends of Nocardia infection over 15 years in a tertiary care hospital. J Clin Pathol 2004; 57: 807–12
- Yildiz O, Alp E, Tokgoz B, Tucer B, Aygen B, Sumerkan B, et al. Nocardiosis in a teaching hospital in the central Anatolia region of Turkey: treatment and outcome. Clin Microbiol Infect 2005; 11: 493–512
- Muñoz J, Mirelis B, Aragon LM, Gutiérrez N, Sánchez F, Espanol M, et al. Clinical and microbiological features of nocardiosis, 1997–2003. J Med Microbiol 2007; 56: 545–50
- Farina C, Andrini L, Bruno G, Sarti M, Tripodi MF, Utili R, et al. Nocardia brasiliensis in Italy: a 9-year experience. Scand J Infect Dis 2007; 39: 969–74
- Pintado V, Gomez-Mampaso E, Fortún J, Meseguer MA, Cobo J, Navas E, et al. Infection with Nocardia species: clinical spectrum of disease and species distribution in Madrid, Spain, 1978–2001. Infection 2002; 30: 338–40
- Maraki S, Scoulica E, Alpantaki K, Dialynas M, Tselentis Y. Lymphocutaneous nocardiosis due to Nocardia brasiliensis. Diagn Microbiol Infect Dis 2003; 47: 341–4
- Christidou A, Maraki S, Scoulica E, Mantadakis E, Agelaki S, Samonis G. Fatal Nocardia farcinica bacteraemia in a patient with lung cancer. Diagn Microbiol Infect Dis 2004; 50: 135–9
- Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard. CLSI 2003; M24–A.
- Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007; 44: 1307–14
- Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, et al. Nocardiosis in cancer patients. Medicine (Baltimore) 2002; 81: 388–97
- Calegari L, Asconeguy F, Conti-Diaz IA. Experimental pathogenicity of Nocardia asteroides, Nocardia brasiliensis and Nocardia caviae from different sources. Sabouraudia 1982; 20: 295–302
- Schaal KP, Lee HJ. Actinomycete infections in humans: a review. Gene 1992; 115: 201–11
- Wallace RJ, Jr, Tsukamura M, Brown BA, Brown J, Steingrube VA, Zhang YS, et al. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol 1990; 28: 2726–32
- Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol 2003; 41: 4497–501
- Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher ES, Birmingham MC, et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis 2003; 36: 313–8
- Jodlowski TZ, Melnychuk I, Contry J. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother 2007; 41: 1694–9
- Cercenado E, Marín M, Sánchez-Martínez M, Cuevas O, Martínez-Alarcón J, Bouza E. In vitro activities of tigecycline and 8 other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother 2007; 51: 1102–4
- Hansen G, Swanzy S, Gupta R, Cookson B, Limaye AP. In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S RNA sequencing. Eur J Clin Microbiol Infect Dis 2008; 27: 115–20
- Santos J, Palacios R, Rivero A, García-Ordóñez MA, Aliaga L, Muniain MA, et al. Grupo andaluz para el estudio de las enfermedades infecciosas GAEI. Nocardiosis in patients with HIV infections. Rev Clin Esp 2004; 204: 237–8